Abbvie (ABBV) PT Lowered to $79 at Credit Suisse
Credit Suisse analyst Vamil Divan lowered the price target on Abbvie (NYSE: ABBV) to $79.00 (from $85.00) while maintaining a Underperform rating.
Credit Suisse analyst Vamil Divan lowered the price target on Abbvie (NYSE: ABBV) to $79.00 (from $85.00) while maintaining a Underperform rating.